Stocks Health care AMIX
NASDAQ · Health careAutonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc. brought in $0 of revenue over the twelve months to June 30, 2026. It posted a net loss of $16.1M. In fiscal 2026 capital spending exceeded operating cash flow by $12.3M. At June 30, 2026 it held $3.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Autonomix Medical, Inc.
- Net worth
- Autonomix Medical, Inc. has a market value (market cap) of $1.6M at the latest share price, and shareholders' equity of $3.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $0, with a net loss of $16.7M. Over the 12 months to June 30, 2026: revenue $0, net loss $16.1M.
- Cash flow
- In fiscal 2026 operations used $12.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Autonomix Medical, Inc.'s next report was expected around November 11, 2026 and is not on file with the SEC yet.
What Autonomix Medical, Inc. does
Autonomix Medical, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker AMIX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $0 | -$16.7M | -$2.32 | -$12.3M |
| 2025 | $0 | -$11.4M | -$6.46 | -$8.3M |
| 2024 | $0 | -$15.4M | -$14.82 | -$6.6M |
| 2024 | $0 | -$2M | -$2.40 | -$1.9M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Autonomix Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 16, 2026
- September 14, 2026Additional proxy material DEFA14A
- September 14, 2026Proxy statement DEF 14A
- September 4, 2026Preliminary proxy statement PRE 14A
- September 4, 2026
- August 26, 2026
- August 13, 2026
- July 28, 2026
- July 28, 2026Other event 8-K
- July 15, 2026
Insider trades
What the people running Autonomix Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 4 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 3, 2026 | Smith Trent N.CFO | Received as pay | 15,000 | - |
| September 3, 2026 | Hauser BradleyCEO and President | Received as pay | 27,000 | - |
| September 3, 2026 | Bisson LoriDirector | Received as pay | 13,000 | - |
| September 3, 2026 | Klemp Walter VDirector | Received as pay | 13,000 | - |
Who owns AMIX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Walter V. Klemp13D, may seek influence | 16% | February 15, 2024 |
| Landy Toth13D, may seek influence | 10.8% | February 26, 2024 |
Largest institutional holders
Insiders
4 insiders reported holding 75,356 shares in total, about $120.6K at the last price.
| Holder | Shares |
|---|---|
| Hauser BradleyCEO and President | 27,000 |
| Klemp Walter VDirector | 20,118 |
| Smith Trent N.CFO | 15,119 |
| Bisson LoriDirector | 13,119 |
Questions about AMIX
What does Autonomix Medical, Inc. do?
Autonomix Medical, Inc. is a company in the Health care sector, listed on NASDAQ as AMIX. Its shares trade on NASDAQ under the ticker AMIX.
What is Autonomix Medical, Inc.'s net worth?
Autonomix Medical, Inc. has a market value (market cap) of $1.6M at the latest share price, and shareholders' equity of $3.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Autonomix Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $16.1M.
How much revenue does Autonomix Medical, Inc. make?
Over the twelve months to June 30, 2026 Autonomix Medical, Inc. reported revenue of $0.
When did Autonomix Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 21, 2026.
When is Autonomix Medical, Inc.'s next earnings report?
Autonomix Medical, Inc.'s next report was expected around November 11, 2026 and is not on file with the SEC yet.
Similar companies
Compare AMIX with
Follow AMIX
Get an email when Autonomix Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Autonomix Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.